senate Bill S2710

Establishes the biosciences commercialization assistance fund within the foundation for science, technology and innovation

download pdf

Sponsor

Co-Sponsors

Bill Status


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor
view actions

actions

  • 31 / Jan / 2011
    • REFERRED TO COMMERCE, ECONOMIC DEVELOPMENT AND SMALL BUSINESS
  • 04 / Jan / 2012
    • REFERRED TO COMMERCE, ECONOMIC DEVELOPMENT AND SMALL BUSINESS
  • 18 / Jan / 2012
    • REPORTED AND COMMITTED TO FINANCE

Summary

Establishes the biosciences commercialization fund within the foundation for science, technology and innovation.

do you support this bill?

Bill Details

See Assembly Version of this Bill:
A9311
Versions:
S2710
Legislative Cycle:
2011-2012
Current Committee:
Senate Finance
Law Section:
Public Authorities Law
Laws Affected:
Amd §3150, add §3154-a, Pub Auth L
Versions Introduced in Previous Legislative Cycles:
2009-2010: S2290, A253
2007-2008: A10256

Sponsor Memo

BILL NUMBER:S2710

TITLE OF BILL:

An act to amend the public authorities law, in relation to
establishing the biosciences commercialization assistance fund within
the foundation for science, technology and innovation

PURPOSE OR GENERAL IDEA OF BILL:

This bill would create a new program within the foundation for
science, technology and innovation to aid the commercialization of
bioscience innovations through grants and assistance to companies and
research institutions.

SUMMARY OF SPECIFIC PROVISIONS:

Section 1 amends section 3150 of the public authorities law by
defining "research entity"and "focus area," Section 2 adds a new
section 3154-a to a new biosciences commercialization assistance and
defines the purposes and uses of the fund. The foundation must give
priority to projects that have the greatest chance of commercial
success. Section 3 makes available funds from the incentive program
part of the research development program. Section 4 establishes the
effectiveness date.

JUSTIFICATION:
Bioscience-based industries such as those manufacturing medical
devices hold an important place in clusters of the knowledge based
economy in New York State. In roundtable discussions hosted by the
Task Force on University-Industry Cooperation and the Commission on
Science and Technology, participants called for new legislative
initiatives that benefit the biosciences industry. It was noted that
the biosciences are and are likely to continue to be very important in
New York State, and that New York continues to be a leader in
attracting research for biosciences research. The need for a set of
commercialization incentives that targets biosciences is highlighted
by the fact that commercialization of bioscience innovations can often
extend to ten or fifteen years reflecting in part the requirement of
extensive clinical trials.

PRIOR LEGISLATIVE HISTORY:
S.2290 of 2009-10; Reported to Finance

FISCAL IMPLICATIONS:
The new fund will depend upon the allocation of available
appropriations

EFFECTIVE DATE:
The act would take effect in 180 days.

view bill text
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  2710

                       2011-2012 Regular Sessions

                            I N  S E N A T E

                            January 31, 2011
                               ___________

Introduced by Sens. GRISANTI, KENNEDY -- read twice and ordered printed,
  and when printed to be committed to the Committee on Commerce, Econom-
  ic Development and Small Business

AN  ACT to amend the public authorities law, in relation to establishing
  the biosciences commercialization assistance fund within  the  founda-
  tion for science, technology and innovation

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 3150 of the public authorities law, as  amended  by
section  4  of  part  C of chapter 63 of the laws of 2005, is amended to
read as follows:
  S 3150. Definitions. As used in this [section] TITLE:
  1. "Foundation" shall mean the New York state foundation for  science,
technology and innovation created by this title;
  2. "Executive director" shall mean the executive director of the foun-
dation;
  3. "Board" shall mean the New York state foundation for science, tech-
nology and innovation board;
  4.  "Regional  partnerships" shall mean any association or group which
is:  (a) comprised of local economic  development  organizations  and  a
center  of  excellence  as defined by section three of part T of chapter
eighty-four of the laws of two thousand two, or in the absence  of  such
center  in  the  region,  at  least  one institution of higher education
involved in commercialization efforts similar to such centers of  excel-
lence  and  may  include  a  combination of private businesses, business
support organizations, commercial lending institutions, venture  capital
companies,  angel  investor  networks or foundations; (b) formed for the
creation and administration of regional partnership  programs;  and  (c)
certified by the foundation as the regional partnership;

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD07604-01-1

S. 2710                             2

  5. "Regional partnership coordinator" shall mean a nonprofit organiza-
tion chosen by a regional partnership and certified by the foundation to
administer the regional partnership programs;
  6. "Partnership" shall mean regional partnerships; [and]
  7. "Coordinator" shall mean regional partnership coordinator[.];
  8.  "RESEARCH ENTITY" SHALL MEAN A NOT-FOR-PROFIT COLLEGE, UNIVERSITY,
MEDICAL CENTER, LABORATORY OR OTHER INSTITUTION THAT CONDUCTS AN  INTEN-
SIVE,  ONGOING  PROGRAM  OF STUDY DIRECTED TOWARD GREATER KNOWLEDGE OF A
SCIENTIFIC FOCUS AREA OR TOWARD APPLYING  NEW  SCIENTIFIC  KNOWLEDGE  TO
MEET A RECOGNIZED NEED;
  9.  "FOCUS  AREA"  SHALL  MEAN BIOSCIENCES RESEARCH INCLUDING, BUT NOT
LIMITED TO, THE BASIC, APPLIED, OR TRANSLATIONAL RESEARCH THAT LEADS  TO
THE  DEVELOPMENT  OF  THERAPEUTICS,  DIAGNOSTICS, OR DEVICES, TO IMPROVE
HUMAN HEALTH OR AGRICULTURE AND  THAT  REQUIRE  FEDERAL  FOOD  AND  DRUG
ADMINISTRATION APPROVAL.
  S  2.  The  public  authorities law is amended by adding a new section
3154-a to read as follows:
  S 3154-A. BIOSCIENCES COMMERCIALIZATION ASSISTANCE FUND. 1. THE  BIOS-
CIENCES  COMMERCIALIZATION  ASSISTANCE  FUND  IS  HEREBY CREATED FOR THE
PURPOSE OF:
  (A) ADVANCING THE EARLY-STAGE DEVELOPMENT  OF  COMMERCIALLY  PROMISING
INVENTIONS  IN  THE FOCUS AREA OWNED BY RESEARCH ENTITIES LOCATED IN NEW
YORK STATE;
  (B) ENCOURAGING ENTREPRENEURS TO FORM NEW  COMPANIES  LOCATED  IN  NEW
YORK STATE TO MANUFACTURE AND MARKET SUCH INVENTIONS;
  (C) ENABLING SMALL BUSINESSES RESIDENT IN THE STATE TO CONDUCT APPLIED
RESEARCH  AND  DEVELOPMENT  NECESSARY  TO  COMMERCIALIZE RESEARCH ENTITY
INVENTIONS; AND
  (D) ENCOURAGING BUSINESSES  RESIDENT  IN  THE  STATE  TO  DEVELOP  NEW
PRODUCTS  OR  PROCESSES  BASED  ON  PROMISING INVENTIONS OR TECHNOLOGIES
OWNED BY SUCH BUSINESSES THROUGH GRANTS OR LOANS TO SUCH RESIDENT  BUSI-
NESSES.
  2.  MONIES  IN THE BIOSCIENCES COMMERCIALIZATION ASSISTANCE FUND SHALL
BE AVAILABLE TO ELIGIBLE RESEARCH ENTITIES, START-UPS, SMALL  COMPANIES,
AND  OTHER BUSINESSES IN NEW YORK STATE, WITH ANTICIPATED COMMERCIALIZA-
TION TIME FRAMES OF UP TO FIFTEEN YEARS, FOR DEVELOPMENT AND COMMERCIAL-
IZATION OF PRODUCTS. THE FOUNDATION SHALL USE THE  MONIES  AVAILABLE  IN
THE BIOSCIENCES COMMERCIALIZATION ASSISTANCE FUND FOR:
  (A)  GRANTS  TO RESEARCH ENTITIES LOCATED IN NEW YORK STATE TO DEVELOP
COMMERCIALLY PROMISING RESEARCH DISCOVERIES IN THE FOCUS AREA BEYOND THE
CONCEPTUAL STAGE IN ORDER TO FURTHER THE CHANCE OF COMMERCIALIZATION AND
INCREASE MARKET VALUE. THE FOUNDATION MAY APPROVE  GRANTS  FOR  ELIGIBLE
PROJECTS,  PROVIDED  SUCH  GRANTS  DO  NOT  EXCEED  ONE HUNDRED THOUSAND
DOLLARS AND ARE USED EXCLUSIVELY TO ACCELERATE THE COMMERCIALIZATION  OF
DISCOVERIES THAT HAVE THE POTENTIAL TO POSITIVELY IMPACT EXISTING COMPA-
NIES  LOCATED  IN  NEW  YORK  OR  LEAD TO THE FORMATION OF NEW COMPANIES
LOCATED IN NEW YORK. GRANTS MAY NOT BE USED TO COMMERCIALIZE DISCOVERIES
THAT WILL BE LICENSED TO FIRMS THAT  DO  NOT  HAVE  THEIR  RESEARCH  AND
DEVELOPMENT  AND MANUFACTURING FACILITIES AND AT LEAST EIGHTY PERCENT OF
THEIR EMPLOYEES LOCATED IN NEW YORK STATE. THE FOUNDATION SHALL  APPROVE
GRANTS  ONLY TO THOSE RESEARCH ENTITIES THAT CAN DEMONSTRATE THE ABILITY
TO GUIDE THE DEVELOPMENT OF THE DISCOVERIES  TOWARD  SUCCESSFUL  COMMER-
CIALIZATION  IN  THE  STATE.  ANY REVENUES EARNED BY THE RESEARCH ENTITY
FROM THE LICENSING OF AN INVENTION DEVELOPED  WITH  A  FOUNDATION  GRANT
MUST  BE  REINVESTED  IN  THE RESEARCH ENTITY'S EDUCATIONAL AND RESEARCH
PROGRAMS OR TECHNOLOGY TRANSFER ACTIVITIES;

S. 2710                             3

  (B) INVESTMENTS IN  START-UP  COMPANIES  FORMED  BY  ENTREPRENEURS  TO
COMMERCIALIZE  INTELLECTUAL  PROPERTY  IN  THE  FOCUS AREA LICENSED FROM
RESEARCH ENTITIES LOCATED IN NEW YORK STATE. THE FOUNDATION MAY  APPROVE
INVESTMENTS  IN  NEW COMPANIES BEING FORMED TO FURTHER DEVELOP, PRODUCE,
AND  SELL  INVENTIONS  LICENSED  FROM  RESEARCH INSTITUTIONS IN NEW YORK
STATE, PROVIDED THAT THE COMPANY'S RESEARCH AND DEVELOPMENT AND/OR MANU-
FACTURING FACILITIES WILL BE LOCATED IN  NEW  YORK  STATE;  THE  COMPANY
COMMITS  TO  REMAINING  IN THE STATE; THE INVESTMENT DOES NOT EXCEED ONE
HUNDRED FIFTY THOUSAND DOLLARS PER COMPANY; AND, THE INVESTMENT IS  USED
SOLELY  FOR OPERATING EXPENSES APPROVED BY THE FOUNDATION. IN RETURN FOR
INVESTMENT BY THE FOUNDATION, THE FOUNDATION SHALL TAKE AN EQUITY  POSI-
TION  IN  THE COMPANY OR NEGOTIATE ROYALTY PAYMENTS BASED ON THE SALE OF
ANY PRODUCTS RESULTING FROM THE LICENSED INVENTION. IN THE EVENT THAT  A
COMPANY  MOVES  ITS RESEARCH AND DEVELOPMENT OR MANUFACTURING FACILITIES
OR MORE THAN TWENTY PERCENT OF ITS EMPLOYEES OUT OF THE STATE, THE FOUN-
DATION SHALL REQUIRE THE COMPANY TO REPAY AN AMOUNT EQUAL  TO  AT  LEAST
FIVE TIMES THE FOUNDATION'S TOTAL INVESTMENT;
  (C)  MATCHING GRANTS TO SMALL BUSINESSES IN NEW YORK STATE FOR COOPER-
ATIVE APPLIED RESEARCH AND DEVELOPMENT PROJECTS IN THE FOCUS  AREA  WITH
RESEARCH INSTITUTIONS TO TRANSLATE PROMISING DISCOVERIES OF THE RESEARCH
INSTITUTION  INTO  COMMERCIALLY  VIABLE  PRODUCTS.  THE  FOUNDATION  MAY
APPROVE MATCHING GRANTS FOR PROJECTS UNDERTAKEN JOINTLY  BY  A  RESEARCH
ENTITY  AND  A BUSINESS INCORPORATED IN NEW YORK STATE FOR UP TO HALF OF
THE COST OF PROJECTS THAT WILL APPLY DISCOVERIES OR USE THE INTELLECTUAL
RESOURCES OF THE RESEARCH ENTITY TO DEVELOP NEW, OR TO IMPROVE EXISTING,
COMMERCIAL  MATERIALS,  DEVICES,  SYSTEMS,  PROCESSES,  OR   PROTOTYPES,
PROVIDED  THAT  THE  GRANTS  DO  NOT  EXCEED  ONE HUNDRED FIFTY THOUSAND
DOLLARS; THE COMPANY HAS LESS THAN ONE HUNDRED FULL-TIME  EMPLOYEES,  AT
LEAST EIGHTY PERCENT OF WHOM WORK IN THE STATE; AND, THE COMPANY HAS ITS
PRINCIPAL  RESEARCH AND DEVELOPMENT AND MANUFACTURING FACILITIES LOCATED
IN THE STATE. IN THE EVENT THAT A COMPANY MOVES ITS RESEARCH AND  DEVEL-
OPMENT  OR  MANUFACTURING  FACILITIES OR MORE THAN TWENTY PERCENT OF ITS
EMPLOYEES OUT OF THE STATE, THE FOUNDATION SHALL REQUIRE THE COMPANY  TO
REPAY  AN  AMOUNT  EQUAL  TO  AT LEAST FIVE TIMES THE FOUNDATION'S TOTAL
INVESTMENT;
  (D) MATCHING GRANTS AND/OR LOANS TO SMALL BUSINESSES IN NEW YORK STATE
FOR COMMERCIAL DEVELOPMENT OF THEIR INNOVATIONS OR TECHNOLOGIES  IN  THE
FOCUS  AREA  INTO  NEW  PRODUCTS  OR PROCESSES TO BE MANUFACTURED IN NEW
YORK.  ANY REPAYMENTS OF LOANS OR EARNINGS ON INVESTMENTS  MADE  BY  THE
FOUNDATION  FROM THE BIOSCIENCES COMMERCIALIZATION ASSISTANCE FUND SHALL
BE DEPOSITED IN SUCH FUND. THE  FOUNDATION  MAY  APPROVE  GRANTS  AND/OR
LOANS  TO  BUSINESSES INCORPORATED IN NEW YORK STATE FOR UP TO ONE-THIRD
OF THE COSTS, INCLUDING WORKFORCE TRAINING, ASSOCIATED WITH THE DEVELOP-
MENT OF NEW PRODUCTS OR PROCESSES FROM INVENTIONS OR TECHNOLOGIES  OWNED
BY  SUCH BUSINESSES, PROVIDED THAT THE GRANT DOES NOT EXCEED TWO HUNDRED
FIFTY THOUSAND DOLLARS; THE COMPANY HAS LESS THAN ONE HUNDRED  FULL-TIME
EMPLOYEES,  AT  LEAST EIGHTY PERCENT OF WHOM WORK IN THE STATE; AND, THE
COMPANY HAS ITS PRINCIPAL RESEARCH  AND  DEVELOPMENT  AND  MANUFACTURING
FACILITIES  LOCATED  IN  THE  STATE.  IN THE EVENT THE COMPANY MOVES ITS
RESEARCH AND DEVELOPMENT OR MANUFACTURING FACILITIES OR MORE THAN TWENTY
PERCENT OF ITS EMPLOYEES OUT OF THE STATE, THE FOUNDATION SHALL  REQUIRE
THE  COMPANY TO REPAY AN AMOUNT EQUAL TO AT LEAST FIVE TIMES THE FOUNDA-
TION'S TOTAL INVESTMENT; AND
  (E) GRANTS TO BUSINESSES IN NEW YORK STATE TO OFFSET SOME  OR  ALL  OF
THE  COSTS OF FILING FOR FEDERAL REGULATORY APPROVAL FOR NEW OR MODIFIED
PRODUCTS OR PROCESSES WITHIN THE FOCUS AREA. THE FOUNDATION MAY  APPROVE

S. 2710                             4

GRANTS  TO  BUSINESSES  INCORPORATED IN NEW YORK STATE PROVIDED THAT THE
COMPANY HAS ITS PRINCIPAL RESEARCH  AND  DEVELOPMENT  AND  MANUFACTURING
FACILITIES  LOCATED  IN  THE  STATE.  IN THE EVENT THE COMPANY MOVES THE
MANUFACTURE OF THE PRODUCT OUT OF NEW YORK STATE WITHIN A PERIOD OF FIVE
YEARS, THE FOUNDATION SHALL REQUIRE THE COMPANY TO REPAY AN AMOUNT EQUAL
TO AT LEAST FIVE TIMES THE FOUNDATION'S TOTAL INVESTMENT. THE FOUNDATION
SHALL  GIVE  PRIORITY  TO COMPANIES WITH LESS THAN ONE HUNDRED FULL-TIME
EMPLOYEES.
  3. PURSUANT TO SECTION THIRTY-ONE HUNDRED FIFTY-ONE OF THIS TITLE, THE
FOUNDATION SHALL PROMULGATE  REGULATIONS  ESTABLISHING  THE  APPLICATION
PROCESS  AND THE CRITERIA THAT WILL BE USED TO EVALUATE APPLICATIONS FOR
GRANTS AND INVESTMENTS FROM THE BIOSCIENCES COMMERCIALIZATION ASSISTANCE
FUND. SUCH REGULATIONS SHALL ALLOW A COMMERCIALIZATION TIME FRAME OF  UP
TO  FIFTEEN  YEARS.  SUCH APPLICATIONS SHALL INCLUDE, BUT NOT BE LIMITED
TO, A DESCRIPTION OF THE EXPECTED SIGNIFICANCE OF  THE  PROJECT  TO  NEW
YORK STATE, INCLUDING THE ESTIMATED NUMBER OF JOBS THAT COULD BE CREATED
AS  A  RESULT  OF THE PROJECT. IN SELECTING APPLICATIONS FOR FUNDING THE
FOUNDATION SHALL GIVE PRIORITY TO THOSE PROJECTS THAT HAVE THE  GREATEST
POTENTIAL  FOR  COMMERCIAL SUCCESS AND EVENTUAL JOB CREATION IN NEW YORK
STATE OR THAT WILL HAVE THE LARGEST POSITIVE IMPACT ON  THE  HEALTH  AND
WELFARE OF THE STATE'S CITIZENS OR ON THE NATURAL OR BUILT ENVIRONMENT.
  S 3. Notwithstanding any other law to the contrary, any appropriations
to  the New York state foundation for science, technology and innovation
board from the general fund, local assistance account for the  incentive
program part of the research development program established pursuant to
section  209-p  of  the  executive  law  that  have not been expended or
committed, as well as any other appropriations that  may  be  so  desig-
nated, may be made available for the purposes of the biosciences commer-
cialization assistance fund.
  S 4. This act shall take effect on the one hundred eightieth day after
it shall have become a law; provided, however, that effective immediate-
ly,  the  addition,  amendment  and/or  repeal of any rule or regulation
necessary for the implementation of this act on its  effective  date  is
authorized  and  directed  to  be  made  and completed on or before such
effective date.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.